SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-135806
Filing Date
2015-04-17
Accepted
2015-04-17 16:19:06
Documents
13
Effectiveness Date
2015-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A d893377ddefa14a.htm DEFA14A 53939
2 GRAPHIC g893377dsp_003a.jpg GRAPHIC 10359
3 GRAPHIC g893377dsp_003b.jpg GRAPHIC 54802
4 GRAPHIC g893377dsp_003c.jpg GRAPHIC 16081
5 GRAPHIC g893377dsp_003d.jpg GRAPHIC 19621
6 GRAPHIC g893377dsp_004.jpg GRAPHIC 10409
7 GRAPHIC g893377dsp_004b.jpg GRAPHIC 13630
8 GRAPHIC g893377dsp_005a.jpg GRAPHIC 10511
9 GRAPHIC g893377dsp_005b.jpg GRAPHIC 23862
10 GRAPHIC g893377dsp_005c.jpg GRAPHIC 25682
11 GRAPHIC g893377dsp_006a.jpg GRAPHIC 10833
12 GRAPHIC g893377dsp_006b.jpg GRAPHIC 10878
13 GRAPHIC g893377dsp_006c.jpg GRAPHIC 31281
  Complete submission text file 0001193125-15-135806.txt   384590
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 15778458
SIC: 2834 Pharmaceutical Preparations